Cutler Group’s Array Biopharma Inc ARRY Stock Holding History

Cutler Group’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,300	Closed	-$2K	–	5060
2019 Q2	$2K	Buy	+4,300	New	+$121K	﹤0.01%	3742
2019 Q1	–	Sell	-2,500	Closed	-$7K	–	5111
2018 Q4	$7K	Hold	2,500	–	–	﹤0.01%	2796
2018 Q3	$7K	Hold	2,500	–	–	﹤0.01%	2911
2018 Q2	$7K	Hold	2,500	–	–	﹤0.01%	2954
2018 Q1	$10K	Buy	+2,500	New	+$40K	﹤0.01%	2829
2017 Q3	–	Sell	-36,800	Closed	-$29K	–	7171
2017 Q2	$29K	Sell	36,800 -152,600	-81%	-$1.25M	﹤0.01%	3054
2017 Q1	$187K	Buy	189,400 +179,500	+1,813%	+$1.91M	0.01%	1245
2016 Q4	$1K	Sell	9,900 -33,800	-77%	-$249K	﹤0.01%	6295
2016 Q3	$9K	Buy	43,700 +40,600	+1,310%	+$157K	﹤0.01%	4387
2016 Q2	$7K	Sell	3,100 -500	-14%	-$1.63K	﹤0.01%	4660
2016 Q1	$8K	Sell	3,600 -26,700	-88%	-$80K	﹤0.01%	4397
2015 Q4	$30K	Buy	+30,300	New	+$138K	﹤0.01%	3007

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Cutler Group's ARRY Position: Q1 2019 in Review

Cutler Group sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 1,500 shares — an estimated $31.2K sold.

Cutler Group first reported a position in ARRY in Q4 2015 and held it in 13 quarters. The position peaked at $539K in Q1 2017. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

Cutler Group reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
Cutler Group sold 1,500 Array Biopharma Inc shares in Q1 2019, an estimated $31.2K.
Cutler Group first reported a position in Array Biopharma Inc in Q4 2015 and held it in 13 quarters.
Cutler Group's Array Biopharma Inc position peaked at $539K in Q1 2017.
268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.